# Andrew S. Bomback

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/andrew-s-bomback/

## Facts

| Field | Value |
| --- | --- |
| Citations | 12,845 |
| Field | Renal Diseases and Glomerulopathies |
| h-index | 57 |
| i10-index | 165 |
| Last Known Institution | Columbia University Irving Medical Center |
| OpenAlex ID | https://openalex.org/A5020881383 |
| ORCID iD | 0000-0001-5449-1667 |
| Works | 324 |

## Researcher papers

Showing 12 of 14.

- [Diagnostic Utility of Exome Sequencing for Kidney Disease](https://scholariq.org/papers/diagnostic-utility-of-exome-sequencing-for-kidney-disease/)
- [An atlas of healthy and injured cell states and niches in the human kidney](https://scholariq.org/papers/an-atlas-of-healthy-and-injured-cell-states-and-niches-in-the-human-kidney/)
- [The incidence and implications of aldosterone breakthrough](https://scholariq.org/papers/the-incidence-and-implications-of-aldosterone-breakthrough/)
- [Eculizumab for Dense Deposit Disease and C3 Glomerulonephritis](https://scholariq.org/papers/eculizumab-for-dense-deposit-disease-and-c3-glomerulonephritis/)
- [The Modern Spectrum of Renal Biopsy Findings in Patients with Diabetes](https://scholariq.org/papers/the-modern-spectrum-of-renal-biopsy-findings-in-patients-with-diabetes/)
- [Postmortem Kidney Pathology Findings in Patients with COVID-19](https://scholariq.org/papers/postmortem-kidney-pathology-findings-in-patients-with-covid-19/)
- [Prevalence of CKD and Comorbid Illness in Elderly Patients in the United States: Results From the Kidney Early Evaluation Program (KEEP)](https://scholariq.org/papers/prevalence-of-ckd-and-comorbid-illness-in-elderly-patients-in-the-united-states/)
- [Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial](https://scholariq.org/papers/efficacy-and-safety-of-sparsentan-versus-irbesartan-in-patients-with-iga/)
- [Change in Proteinuria After Adding Aldosterone Blockers to ACE Inhibitors or Angiotensin Receptor Blockers in CKD: A Systematic Review](https://scholariq.org/papers/change-in-proteinuria-after-adding-aldosterone-blockers-to-ace-inhibitors-or/)
- [KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for Glomerulonephritis](https://scholariq.org/papers/kdoqi-us-commentary-on-the-2012-kdigo-clinical-practice-guideline-for/)
- [Mycophenolate Mofetil in Combination with Steroids for Treatment of C3 Glomerulopathy](https://scholariq.org/papers/mycophenolate-mofetil-in-combination-with-steroids-for-treatment-of-c3/)
- [Lupus Podocytopathy: An Overview](https://scholariq.org/papers/lupus-podocytopathy-an-overview/)

## Researcher topics

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Complement system in diseases](https://scholariq.org/topics/complement-system-in-diseases/)
- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions/)
- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)

## Researcher university

- [Columbia University Irving Medical Center](https://scholariq.org/institutions/columbia-university-irving-medical-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.